Related Experiment Videos
No significant correlation between specific antibodies to mouse mammary tumour virus and human cancer
A Kovarík1, K Hlubinová, J Prachar
1Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Czechoslovakia.
Abstract:
To study the possible involvement of mouse mammary tumour virus (MMTV) related agent in human cancer we analysed 300 samples of human sera for the presence of antibodies to MMTV structural proteins. All sera were tested by immunoblotting to achieve high specificity. Out of 300 sera, 22 reacted with transframe protein p30, 16 with the ribonucleoprotein p14, six with the envelope glycoprotein gp52 and three with the major core protein p27. Reactivities to p30 and p14 were observed in sera from cancer patients and healthy controls; reactivities to p27 and gp52 predominated in sera of cancer patients. Sera frequently reacted with a 42 kDa protein which is a cellular contaminant of the virus.
Insights
This study investigated mouse mammary tumour virus (MMTV) in human cancer by analyzing antibodies in human sera. MMTV-related proteins showed varied reactivity, with some predominantly found in cancer patients, suggesting a potential link.
Area of Science:
- Oncology
- Virology
- Immunology
Background:
- The potential role of mouse mammary tumour virus (MMTV) in human cancers remains an area of investigation.
- MMTV is a retrovirus known to cause mammary tumors in mice.
Purpose of the Study:
- To investigate the presence of antibodies against MMTV structural proteins in human sera.
- To explore the association between MMTV-related agents and human cancer.
Main Methods:
- Analysis of 300 human serum samples.
- Immunoblotting assay to detect antibodies against specific MMTV proteins (p30, p14, gp52, p27).
- Distinguishing reactivity patterns between cancer patients and healthy controls.
Main Results:
- Antibodies to MMTV proteins p30 and p14 were found in both cancer patients and healthy individuals.
- Antibodies to MMTV proteins p27 and gp52 showed higher prevalence in cancer patients.
- A significant number of sera reacted with a 42 kDa protein, identified as a cellular contaminant.
Conclusions:
- The study suggests a potential association between MMTV-related agents and human cancer, particularly indicated by antibodies to p27 and gp52.
- The presence of antibodies to MMTV proteins warrants further investigation into their etiological role in human malignancies.
- Cellular contaminants in viral preparations can lead to non-specific antibody reactions, necessitating careful interpretation.